Targeting of PCSK9 with siRNA for LDL-C Reduction in a High-Risk Population. Expires on October 01, 2020 Eligible for Internal Medicine, Endocrinology, Cardiology, Vascular Medicine, and Primary Care Specialists. IPOKRATE team has selected this CME activity. Register, complete & earn CME credits...